Canada Rx Weekly | Oct 19, 2026 Edition

MEDFAR, the Canadian healthcare technology company behind the MYLE electronic medical record (EMR) platform, has acquired AI conversational agent developer AlloMia, marking its second AI technology acquisition in under two years. AlloMia's AI voice agent answers patient calls around the clock, manages requests, and books appointments directly into clinic schedules. In recently onboarded pilot clinics, it independently handles approximately 50% of calls from start to finish. The acquisition adds a fourth AI capability to MYLE, alongside AI Scribe, AI Form-Filling, and AI Indexing, extending automation across clinical documentation, administrative workflows, and patient communication. The AlloMia team has joined MEDFAR, and the solution is now available to all MYLE clinics. It also integrates with Plexia and Medgen EMRs, extending its reach beyond the MYLE ecosystem.